Home-based Gait Rehabilitation Service Using Instrumented Insole
Launched by YONSEI UNIVERSITY · May 7, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how an insole gait analyzer can help people with walking difficulties. The researchers want to find out if using this special device at home can improve walking patterns by providing feedback and monitoring during exercises. They will also check how satisfied participants are with this insole system after using it for six weeks.
To join the study, participants need to be adults over 19 years old who can walk and have a certain level of mobility. They will wear the insole while doing a home exercise program and will complete a satisfaction survey at the end. This trial is currently recruiting participants, and it’s important to note that those with certain medical issues, like severe joint problems or unstable brain diseases, may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults over 19 years of age
- • 2. Patients with a score of 2-3 on the Modified Rankin Scale who are ambulatory
- • 3. Patients who visited Yongin Severance Hospital who understood and agreed to the study and completed the informed consent form
- Exclusion Criteria:
- • 1. Those with contraindications to lower extremity weight bearing such as severe lower extremity joint contractures, osteoporosis, or untreated fractures
- • 2. Progressive or unstable brain disease
- • 3. In addition to above, those who have clinically significant findings that are deemed inappropriate for this study in the medical judgment of the study director or person in charge
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yongin Si, Gyeonggi Do, Korea, Republic Of
Patients applied
Trial Officials
Na Young Kim, MD, PhD
Principal Investigator
Severance Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported